Mandate

Vinge advises on transactions between Platzer and Länsförsäkringar

April 12, 2019 Private Equity

Vinge has advised Platzer Fastigheter in connection with the company’s entry into of an agreement with Länsförskringar Göteborg and Bohuslän concerning the transfer of half of the participating interests in the subsidiary with owns the property Gårda Vesta.

A building is currently being erected on the property which will include approximately 27 800 m2 of office space and will be completed in 2021. The parties have also entered into a lease agreement whereby Länsförsäkringar will rent 5 360 m2 of office space in Gårda Vesta. Since Länsförsäkringar is one of the largest shareholders in Platzer Fastigheter, the transaction was approved by the annual general meeting in 2018. The asset purchase agreement and lease agreement have been included in the same resolution adopted at the annual general meeting. As of the date of the annual general meeting, the property was valued at MSEK 1 300.

Vinge’s team primarily consisted of Olof Jisland, Assur Badur, Kristoffer Larson, Ulf Nilsson, Victor Ericsson and Nils Fredrik Dehlin.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025